Breast Cancer in Men

This content has been reviewed and approved by

William J. Gradishar, MD FACP
Director, Breast Medical Oncology, Professor of Medicine
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
 

Statistics Regarding Men and Breast Cancer


Breast cancer in men is rare—less than 1 percent of all breast carcinomas occur in men. Consider the latest statistics available from the American Cancer Society (ACS):

  • The ACS estimates that in 2008, approximately 1,990 new cases of invasive breast cancer will have been diagnosed among men in the United States. Breast cancer is about 100 times more common among women. The average age at diagnosis is 67, although men of all ages can be affected with the disease.

What are risk factors for breast cancer in men?

Risk factors may include:

  • Radiation exposure
  • Estrogen administration
  • Diseases associated with hyperestrogenism, such as cirrhosis or Klinefelter's syndrome
Also, there are definite familial tendencies for developing breast cancer.
  • An increased incidence is seen in men who have a number of female relatives with breast cancer.
  • An increased risk of male breast cancer has been reported in families in which a BRCA2 gene mutation has been identified.

What is the most common type of breast cancer in men?

Infiltrating ductal cancer is the most common tumor type, but intraductal cancer, inflammatory carcinoma, and Paget's disease of the nipple have been seen as well.
Lobular carcinoma in situ is very rare in men.

What are the symptoms of breast cancer in men?

The following are the most common symptoms of breast cancer in men. However, each individual may experience symptoms differently. Symptoms may include:

  • Breast lumps
  • Nipple inversion
  • Nipple discharge (sometimes bloody)
  • A pain or pulling sensation in the breast
The symptoms of breast cancer may resemble other medical conditions or problems. Always consult your physician for a diagnosis.

What are the similarities to breast cancer in women?

Lymph node involvement and the hematogenous pattern of spread are similar to those found in female breast cancer. The staging system for male breast cancer is identical to the staging system for female breast cancer. Prognostic factors that have been evaluated include the size of lesion and the presence or absence of lymph node involvement, both of which correlate well with prognosis.

Overall survival rates are similar to that of women with breast cancer. The impression that male breast cancer has a worse prognosis may stem from the tendency toward diagnosis at a later stage.

Treatment for Men with Breast Cancer

Specific treatment for male breast cancer will be determined by your physician based on:

  • Your age, overall health, and medical history
  • Extent of the disease
  • Your tolerance for specific medications, procedures, or therapies
  • Expectations for the course of the disease
  • Your opinion or preference
The primary standard treatment is a modified radical mastectomy because breast- conserving therapy is not an option due to the lack of glandular breast tissue in men. Other treatment may include:

  • Radiation therapy - Radiation therapy is a process that precisely sends high levels of radiation directly to the cancer cells. Radiation done after surgery can kill cancer cells that may not be seen during surgery. Radiation may also be done:

    • Before surgery to shrink the tumor.
    • In combination with chemotherapy.
    • As a palliative treatment (therapy that relieves symptoms, such as pain, but does not alter the course of the disease).

Radiation therapy is usually delivered by external beam radiation. External radiation (also called external beam therapy) is a treatment that precisely sends high levels of radiation directly to the cancer cells. The machine is controlled by the radiation therapist. Since radiation is used to kill cancer cells and to shrink tumors, special shields may be used to protect the tissue surrounding the treatment area. Radiation treatments are painless and usually last a few minutes.

  • Chemotherapy - Chemotherapy is the use of anticancer drugs to treat cancerous cells. In most cases, chemotherapy works by interfering with the cancer cell's ability to grow or reproduce. Different groups of drugs work in different ways to fight cancer cells. The oncologist will recommend a treatment plan for each individual.
  • Hormone therapy - In some cases, hormones can kill cancer cells, slow the growth of cancer cells, or stop cancer cells from growing. Hormone therapy as a cancer treatment involves taking substances to interfere with the activity of hormones or to stop the production of hormones.

Before you begin hormone therapy, your physician may recommend a hormone receptor test. This lab test is performed on a tissue sample to determine if estrogen and progesterone receptors are present. A hormone receptor test can help to predict whether cancer cells are sensitive to hormones. Tamoxifen is the standard endocrine treatment for men with hormone-sensitive disease.

The hormone estrogen is present in men, as well as in women. Estrogen can increase the growth of breast cancer cells in some men. Hormone therapy may be recommended for men whose breast cancers test positive for estrogen receptors. Antiestrogens, such as tamoxifen, are most often used in hormone therapy of breast cancer in both men and women.

  • Adjuvant therapy - Radiation therapy, chemotherapy, or hormone therapy are given after surgery for the removal of cancer as a safety factor to kill any cancer cells that cannot be seen. Adjuvant therapy may be considered on the same basis as it is for a woman with breast cancer because there is no evidence that the prognosis is different between men and women.
This content was last modified on May 18, 2007 .
Latest Breast Cancer News
HHS says U.S. policy on mammograms unchanged

November 18, 2009 — CHICAGO (Reuters) - U.S. health officials on Wednesday distanced themselves from controversial new breast cancer screening guidelines that recommend against routine mammograms for healthy women in their 40s and said federal policy on screening mammograms has not changed.

Experts question motives of mammogram guidelines

November 17, 2009 — CHICAGO (Reuters) - Cancer experts fear new U.S. breast imaging guidelines that recommend against routine screening mammograms for women in their 40s may have their roots in the current drive in Washington to reform healthcare.

New US guidelines: routine mammograms start at 50

November 16, 2009 — CHICAGO, Nov 16 (Reuters) - Sweeping new U.S. breast cancer guidelines released on Monday recommend against routine mammograms for women in their 40s, and suggest women 50 to 74 only get a mammogram every other year.

Select news items provided by Reuters Health